Drug Database
L01AA09 bendamustine
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Bendamustine hydrochloride 180 mg/4 ml Concentrate For Solution For Infusion
- POM Bendamustine hydrochloride 2.5 mg/ml powder for concentrate for solution for infusion
- POM Bendamustine hydrochloride 2.5 mg/ml powder for concentrate for solution for infusion
- POM Bendamustine hydrochloride 2.5 mg/ml Powder for concentrate for solution for infusion
- POM Bendamustine hydrochloride 2.5mg/ml Powder
- POM Bendamustine Hydrochloride 2.5mg/ml powder for concentrate for solution for infusion
- POM Bendamustine hydrochloride 25 mg/ml concentrate for solution for infusion
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).